Interventions for American cutaneous and mucocutaneous leishmaniasis-Reference-Cited by-同舟云学术

Interventions for American cutaneous and mucocutaneous leishmaniasis

Published:2020-08-27 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Pinart Mariona¹,Rueda José-Ramón²,Romero Gustavo AS³,Pinzón-Flórez Carlos Eduardo⁴,Osorio-Arango Karime⁵,Silveira Maia-Elkhoury Ana Nilce⁶,Reveiz Ludovic⁷,Elias Vanessa M⁷,Tweed John A⁸

Affiliation:

1. Free time independent Cochrane reviewer; Berlin Germany

2. Department of Preventive Medicine and Public Health; University of the Basque Country; Leioa Spain

3. Center for Tropical Medicine; University of Brasilia; Brasilia Brazil

4. Research Centre for Insurance Medicine; Keralty; Bogotá Colombia

5. Dirección de Redes en Salud Pública; Instituto Nacional de Salud; Bogotá Colombia

6. Communicable Diseases and Environmental Determinants of Health (CDE), Neglected, Tropical and Vector Borne Diseases (VT); Pan American Health Organization/ World Health Organization (PAHO/WHO); Rio de Janeiro Brazil

7. Evidence and Intelligence for Action in Health Department; Pan American Health Organization (PAHO); Washington DC USA

8. c/o Cochrane Skin Group; The University of Nottingham; Nottingham UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference270 articles.

1. Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony stimulating factor versus stibogluconate alone in the treatment of cutaneous leishmaniasis;Almeida;Journal of Infectious Diseases,1999

2. The efficacy of pentamidine in comparison to pentavalent antimonial in American tegumentary leishmaniasis: an open label, randomized, controlled trial;Alves;Journal of the American Academy of Dermatology,2016

3. Avaliation the therapeutic efficacy of fluconazol;Alves Norões;International Archives of Medicine,2015

4. Comparison of meglumine and pentamidine for Peruvian cutaneous leishmaniasis;Andersen;American Journal of Tropical Medicine and Hygiene,2005

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Core Outcome Measure Instrument; "LeishCOM_LCL”, for Localised Cutaneous Leishmaniasis;PLOS Neglected Tropical Diseases;2024-08-29

2. Demographic characteristics and clinical features of patients presenting with different forms of cutaneous leishmaniasis, in Lay Gayint, Northern Ethiopia;PLOS Neglected Tropical Diseases;2024-08-15

3. Termoterapia versus tratamiento intralesional para leishmaniasis cutánea: Un metaanálisis de ensayos clínicos controlados;Gaceta Médica Boliviana;2024-06-28

4. Development of a Core Outcome Measure Instrument; “LeishCOM_LCL”, for Localised Cutaneous Leishmaniasis;2024-05-28

5. OPÇÕES MEDICAMENTOSAS NO TRATAMENTO DA LEISHMANIOSE TEGUMENTAR AMERICANA CUTÂNEA;Revista Contemporânea;2024-03-18